Last reviewed · How we verify

NCT06722547

Respiratory Muscle Stretching Exercise for Improving Quality of Life of Patients With Bronchiectasis

Completed NA Last updated 25 February 2025
What this trial tests

NA trial testing Standard PR in Bronchiectasis Post-Tuberculosis Lung Disease in 50 participants. Completed in 27 January 2025.

Timeline
17 January 2024
Primary endpoint
27 January 2025
27 January 2025

Quick facts

Lead sponsorUniversitas Padjadjaran
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment50
Start date17 January 2024
Primary completion27 January 2025
Estimated completion27 January 2025
Sites1 location across Indonesia

Drugs / interventions tested

Conditions studied

Sponsor

Universitas Padjadjaran — full company profile →

Who can join

Adults 18 to 59, any sex, with Bronchiectasis Post-Tuberculosis Lung Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Bronchiectasis is a chronic condition often arising after the successful treatment of lung tuberculosis, leading to diminished functional exercise capacity, increased fatigue, and reduced quality of life. This randomized controlled trial aims to evaluate the efficacy of adding Respiratory Muscle Stretching (RMS) exercises to standard pulmonary rehabilitation in improving functional exercise capacity, reducing fatigue, and enhancing the quality of life in patients with bronchiectasis post-tuberculosis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Standard PR

Trials testing the same drug.

Other Universitas Padjadjaran trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06722547.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing